Novo Nordisk Announces Exit Of China chief Christine Zhou
January 30, 2026
6:23 am
Novo Nordisk’s long-serving head of China operations, Christine Zhou, will step down at the end of March, the Danish pharmaceutical company announced Friday, as competition accelerates in the world’s second-largest drug market.
The company said in a statement published on its official WeChat account that Zhou, a senior vice president who has led Novo Nordisk’s business across mainland China, Taiwan, Hong Kong, and Macau since 2018, will leave the company after overseeing a critical period of expansion and regulatory approvals.
The leadership change comes as Novo Nordisk faces rising pressure from Eli Lilly and an expanding field of Chinese pharmaceutical …
